NCT05283239View on ClinicalTrials.gov

Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2024

Conditions
HPV InfectionLSIL, Low-Grade Squamous Intraepithelial LesionsHSIL, High-Grade Squamous Intraepithelial LesionsVirus Integration
Interventions
OTHER

Follow up

Participants will be followed up at 6th，12th, 18th and 24th months with HPV viral integration/genotyping tests, thinprep cytologic tests (TCT) for cervix and vaginal secretion tests. Colposcopy and biopsy will be conducted for participants if necessary.

Trial Locations (11)

350001

RECRUITING

Fujian Maternity and Child Health Hospital, Fuzhou

351100

RECRUITING

The First Hospital of Putian City, Putian

352000

RECRUITING

Mindong Hospital of Ningde City, Ningde

352100

RECRUITING

Ningde Municipal Hospital of Ningde Normal University, Ningde

361000

RECRUITING

Xiamen Maternity and Child Health Hospital Affiliated to Xiamen University, Xiamen

362000

RECRUITING

Quanzhou First Hospital Afflicated to Fujian Medical University, Quanzhou

363000

RECRUITING

Zhangzhou affiliated Hospital of Fujian Medical University, Zhangzhou

Unknown

RECRUITING

Longyan First Hospital, Longyan

RECRUITING

Nanping Second Hospital, Nanjing

RECRUITING

Sanming Second Hospital, Sanming

RECRUITING

Shenzhen Maternity and child Healthcare Hospital, Shenzhen

All Listed Sponsors
lead

Fujian Maternity and Child Health Hospital

OTHER